← Eichor
Study identifier: NCT07131475 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure

Condition: Blast Injury  ·  Sponsor: Massachusetts General Hospital

PhasePhase 2
Planned participants100
Who can joinMale, 18 Years to 50 Years
Healthy volunteersNo

About this study

This is a 4-year, longitudinal study of 100 active-duty Navy SEALs. The goal of the study is to determine whether repeated blast exposure affects SEAL brain health and to develop an initial diagnostic testing protocol that detects repeated blast brain injury.

This description comes directly from the study's public registry record.

Talk to the study team

Brian L Edlow, M.D.  ·  617-724-6352  ·  bedlow@mgh.harvard.edu

Michael A Gordon, B.s.  ·  617-724-6352  ·  magordon@mgh.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Massachusetts General HospitalBoston, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07131475